Side Effects of Combination Therapy of Peginterferon and Ribavirin for Chronic Hepatitis-C-Reference-Cited by-同舟云学术

Side Effects of Combination Therapy of Peginterferon and Ribavirin for Chronic Hepatitis-C

Published:2007 Issue:22 Volume:46 Page:1827-1832
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Arase Yasuji¹,Suzuki Fumitaka¹,Suzuki Yoshiyuki¹,Akuta Norio¹,Kawamura Yusuke¹,Kobayashi Masahiro¹,Hosaka Tetsuya¹,Sezaki Hitomi¹,Yatsuji Hiromi¹,Kobayashi Mariko²,Ikeda Kenji¹,Kumada Hiromitsu¹

Affiliation:

1. Department of Hepatology, Toranomon Hospital

2. Hepatic Research Unit, Toranomon Hospital

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

http://www.jstage.jst.go.jp/article/internalmedicine/46/22/46_22_1827/_pdf

Reference17 articles.

1. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

2. Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

3. Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C

4. Side effects of high-dose interferon therapy for chronic hepatitis C

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OW THE HEPATITIS C VIRUS WAS DISCOVERED, OR THE DETECTIVE SEARCHES OF VIROLOGISTS FOR THE SILENT KILLER;Visnik Nacional'noi' academii' nauk Ukrai'ni;2020-12-20

2. Generation Gap for Screening and Treatment of Hepatitis C Virus in Saga Prefecture, Japan: An Administrative Database Study of 35,625 Subjects;Internal Medicine;2020-01-15

3. Meta-Analysis of Combination Therapy of Chinese Herbs Plus Interferon and Ribavirin in Patients with Chronic Hepatitis C;Medical Science Monitor;2016-05-30

4. Randomized trial of low-dose peginterferon α-2b plus low and escalating doses of ribavirin in older patients with chronic hepatitis C with high viral load genotype 1;Journal of Medical Virology;2015-06-16

5. Bacterial Infection as an Adverse Effect of Telaprevir-based Triple Therapy for Chronic Hepatitis C Infection;Internal Medicine;2015